抗凝固薬の世界市場:販売動向2018

【英語タイトル】Global Anticoagulant Drugs Sales Market Report 2018

QYResearchが出版した調査資料(QYR80700901)・商品コード:QYR80700901
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、 抗凝固薬の世界市場について調査・分析し、 抗凝固薬のメーカー別販売量、市場シェア分析、種類別販売分析(未分画ヘパリン、ワルファリン、低分子量ヘパリン、 第Xa因子インヒビター、直接阻害インヒビター、その他)、用途別販売分析(病院、研究所)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、 抗凝固薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ 抗凝固薬市場概要
・ 抗凝固薬のメーカー別販売量・メーカー別シェア
・ 抗凝固薬の世界市場:種類別販売量(未分画ヘパリン、ワルファリン、低分子量ヘパリン、 第Xa因子インヒビター、直接阻害インヒビター、その他)
・ 抗凝固薬の世界市場:用途別販売量(病院、研究所)
・ 抗凝固薬の世界市場:地域別販売量・市場シェア
・ 抗凝固薬の米国市場規模
・ 抗凝固薬の中国市場規模
・ 抗凝固薬の欧州市場規模
・ 抗凝固薬の日本市場規模
・ 抗凝固薬の東南アジア市場規模
・ 抗凝固薬のインド市場規模
・ 抗凝固薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・ 抗凝固薬のコスト分析・価格動向
・ 抗凝固薬の産業チェーン(サプライチェーン分析)
・ 抗凝固薬のマーケティング戦略・販売チャネル、流通業者
・ 抗凝固薬市場への影響要因分析
・ 抗凝固薬の世界市場予測
・ 抗凝固薬の米国市場予測
・ 抗凝固薬の中国市場予測
・ 抗凝固薬の欧州市場予測
・ 抗凝固薬の日本市場予測
・ 抗凝固薬の東南アジア市場予測
・ 抗凝固薬のインド市場予測
・ 抗凝固薬の種類別世界市場予測(未分画ヘパリン、ワルファリン、低分子量ヘパリン、 第Xa因子インヒビター、直接阻害インヒビター、その他)
・ 抗凝固薬の用途別世界市場予測(病院、研究所)
...
【レポートの概要】

This report studies the global Anticoagulant Drugs market status and forecast, categorizes the global Anticoagulant Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Antithrombotic drugs are used to reduce the formation of blood clots.
Blood normally flows through arteries and veins in the circulatory system, but clot formation can block the flow of blood, which results in thrombosis. Clot formation in blood vessels is primarily the reason of various diseases that include heart attack, stroke, and venous thrombosis.
The global Anticoagulant Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Sanofi
Bristol-Myers Squibb
Jansen (Johnson & Johnson)
Boehringer Ingelheim
Johnson & Johnson
Bayer

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Unfractionated Heparin
Warfarin
Low Molecular Weight Heparin
Factor XA Inhibitors
Direct Inhibition Inhibitors
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hosptial
Lab use

The study objectives of this report are:
To analyze and study the global Anticoagulant Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Anticoagulant Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anticoagulant Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anticoagulant Drugs Manufacturers
Anticoagulant Drugs Distributors/Traders/Wholesalers
Anticoagulant Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anticoagulant Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Anticoagulant Drugs Sales Market Report 2018
1 Anticoagulant Drugs Market Overview
1.1 Product Overview and Scope of Anticoagulant Drugs
1.2 Classification of Anticoagulant Drugs by Product Category
1.2.1 Global Anticoagulant Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Anticoagulant Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Unfractionated Heparin
1.2.4 Warfarin
1.2.5 Low Molecular Weight Heparin
1.2.6 Factor XA Inhibitors
1.2.7 Direct Inhibition Inhibitors
1.2.8 Others
1.3 Global Anticoagulant Drugs Market by Application/End Users
1.3.1 Global Anticoagulant Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hosptial
1.3.2 Lab use
1.4 Global Anticoagulant Drugs Market by Region
1.4.1 Global Anticoagulant Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Anticoagulant Drugs Status and Prospect (2013-2025)
1.4.3 Europe Anticoagulant Drugs Status and Prospect (2013-2025)
1.4.4 China Anticoagulant Drugs Status and Prospect (2013-2025)
1.4.5 Japan Anticoagulant Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Anticoagulant Drugs Status and Prospect (2013-2025)
1.4.7 India Anticoagulant Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Anticoagulant Drugs (2013-2025)
1.5.1 Global Anticoagulant Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Anticoagulant Drugs Revenue and Growth Rate (2013-2025)

2 Global Anticoagulant Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Anticoagulant Drugs Market Competition by Players/Suppliers
2.1.1 Global Anticoagulant Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Anticoagulant Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Anticoagulant Drugs (Volume and Value) by Type
2.2.1 Global Anticoagulant Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Anticoagulant Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Anticoagulant Drugs (Volume and Value) by Region
2.3.1 Global Anticoagulant Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Anticoagulant Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Anticoagulant Drugs (Volume) by Application

3 United States Anticoagulant Drugs (Volume, Value and Sales Price)
3.1 United States Anticoagulant Drugs Sales and Value (2013-2018)
3.1.1 United States Anticoagulant Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Anticoagulant Drugs Sales Price Trend (2013-2018)
3.2 United States Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Anticoagulant Drugs (Volume, Value and Sales Price)
4.1 Europe Anticoagulant Drugs Sales and Value (2013-2018)
4.1.1 Europe Anticoagulant Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Anticoagulant Drugs Sales Price Trend (2013-2018)
4.2 Europe Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Anticoagulant Drugs (Volume, Value and Sales Price)
5.1 China Anticoagulant Drugs Sales and Value (2013-2018)
5.1.1 China Anticoagulant Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Anticoagulant Drugs Sales Price Trend (2013-2018)
5.2 China Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Anticoagulant Drugs (Volume, Value and Sales Price)
6.1 Japan Anticoagulant Drugs Sales and Value (2013-2018)
6.1.1 Japan Anticoagulant Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Anticoagulant Drugs Sales Price Trend (2013-2018)
6.2 Japan Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Anticoagulant Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Anticoagulant Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Anticoagulant Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Anticoagulant Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Anticoagulant Drugs (Volume, Value and Sales Price)
8.1 India Anticoagulant Drugs Sales and Value (2013-2018)
8.1.1 India Anticoagulant Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Anticoagulant Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Anticoagulant Drugs Sales Price Trend (2013-2018)
8.2 India Anticoagulant Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Anticoagulant Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Anticoagulant Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Anticoagulant Drugs Players/Suppliers Profiles and Sales Data
9.1 Sanofi
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Anticoagulant Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Sanofi Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Anticoagulant Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Jansen (Johnson & Johnson)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Anticoagulant Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Jansen (Johnson & Johnson) Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Anticoagulant Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Anticoagulant Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson & Johnson Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Bayer
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Anticoagulant Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bayer Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview

10 Anticoagulant Drugs Maufacturing Cost Analysis
10.1 Anticoagulant Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Anticoagulant Drugs
10.3 Manufacturing Process Analysis of Anticoagulant Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Anticoagulant Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anticoagulant Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Anticoagulant Drugs Market Forecast (2018-2025)
14.1 Global Anticoagulant Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Anticoagulant Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Anticoagulant Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Anticoagulant Drugs Price and Trend Forecast (2018-2025)
14.2 Global Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Anticoagulant Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Anticoagulant Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Anticoagulant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Anticoagulant Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Anticoagulant Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Anticoagulant Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Anticoagulant Drugs Price Forecast by Type (2018-2025)
14.4 Global Anticoagulant Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Anticoagulant Drugs
Figure Global Anticoagulant Drugs Sales Volume Comparison (MT) by Type (2013-2025)
Figure Global Anticoagulant Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Unfractionated Heparin Product Picture
Figure Warfarin Product Picture
Figure Low Molecular Weight Heparin Product Picture
Figure Factor XA Inhibitors Product Picture
Figure Direct Inhibition Inhibitors Product Picture
Figure Others Product Picture
Figure Global Anticoagulant Drugs Sales Comparison (MT) by Application (2013-2025)
Figure Global Sales Market Share of Anticoagulant Drugs by Application in 2017
Figure Hosptial Examples
Table Key Downstream Customer in Hosptial
Figure Lab use Examples
Table Key Downstream Customer in Lab use
Figure Global Anticoagulant Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anticoagulant Drugs Sales Volume (MT) and Growth Rate (2013-2025)
Figure Global Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Anticoagulant Drugs Sales Volume (MT) (2013-2018)
Table Global Anticoagulant Drugs Sales (MT) of Key Players/Suppliers (2013-2018)
Table Global Anticoagulant Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Anticoagulant Drugs Sales Share by Players/Suppliers
Figure 2017 Anticoagulant Drugs Sales Share by Players/Suppliers
Figure Global Anticoagulant Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anticoagulant Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anticoagulant Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Anticoagulant Drugs Revenue Share by Players
Table 2017 Global Anticoagulant Drugs Revenue Share by Players
Table Global Anticoagulant Drugs Sales (MT) and Market Share by Type (2013-2018)
Table Global Anticoagulant Drugs Sales Share (MT) by Type (2013-2018)
Figure Sales Market Share of Anticoagulant Drugs by Type (2013-2018)
Figure Global Anticoagulant Drugs Sales Growth Rate by Type (2013-2018)
Table Global Anticoagulant Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Anticoagulant Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anticoagulant Drugs by Type (2013-2018)
Figure Global Anticoagulant Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Anticoagulant Drugs Sales Volume (MT) and Market Share by Region (2013-2018)
Table Global Anticoagulant Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Anticoagulant Drugs by Region (2013-2018)
Figure Global Anticoagulant Drugs Sales Growth Rate by Region in 2017
Table Global Anticoagulant Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anticoagulant Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anticoagulant Drugs by Region (2013-2018)
Figure Global Anticoagulant Drugs Revenue Growth Rate by Region in 2017
Table Global Anticoagulant Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anticoagulant Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anticoagulant Drugs by Region (2013-2018)
Figure Global Anticoagulant Drugs Revenue Market Share by Region in 2017
Table Global Anticoagulant Drugs Sales Volume (MT) and Market Share by Application (2013-2018)
Table Global Anticoagulant Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Anticoagulant Drugs by Application (2013-2018)
Figure Global Anticoagulant Drugs Sales Market Share by Application (2013-2018)
Figure United States Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure United States Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table United States Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table United States Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table United States Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table United States Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table United States Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table United States Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Figure Europe Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Europe Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Europe Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table Europe Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table Europe Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table Europe Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table Europe Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table Europe Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Figure China Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure China Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table China Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table China Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table China Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table China Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table China Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table China Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Figure Japan Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Japan Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Japan Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table Japan Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table Japan Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table Japan Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table Japan Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table Japan Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Southeast Asia Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Southeast Asia Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Figure India Anticoagulant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure India Anticoagulant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Anticoagulant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table India Anticoagulant Drugs Sales Volume (MT) by Players (2013-2018)
Table India Anticoagulant Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Anticoagulant Drugs Sales Volume Market Share by Players in 2017
Table India Anticoagulant Drugs Sales Volume (MT) by Type (2013-2018)
Table India Anticoagulant Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Anticoagulant Drugs Sales Volume Market Share by Type in 2017
Table India Anticoagulant Drugs Sales Volume (MT) by Application (2013-2018)
Table India Anticoagulant Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Anticoagulant Drugs Sales Volume Market Share by Application in 2017
Table Sanofi Basic Information List
Table Sanofi Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Sanofi Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Anticoagulant Drugs Sales Global Market Share (2013-2018)
Figure Sanofi Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Anticoagulant Drugs Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Jansen (Johnson & Johnson) Basic Information List
Table Jansen (Johnson & Johnson) Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Jansen (Johnson & Johnson) Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Jansen (Johnson & Johnson) Anticoagulant Drugs Sales Global Market Share (2013-2018
Figure Jansen (Johnson & Johnson) Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Anticoagulant Drugs Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Johnson & Johnson Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Anticoagulant Drugs Sales Global Market Share (2013-2018)
Figure Johnson & Johnson Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Bayer Basic Information List
Table Bayer Anticoagulant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Bayer Anticoagulant Drugs Sales Growth Rate (2013-2018)
Figure Bayer Anticoagulant Drugs Sales Global Market Share (2013-2018
Figure Bayer Anticoagulant Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulant Drugs
Figure Manufacturing Process Analysis of Anticoagulant Drugs
Figure Anticoagulant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulant Drugs Major Players in 2017
Table Major Buyers of Anticoagulant Drugs
Table Distributors/Traders List
Figure Global Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Global Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anticoagulant Drugs Price (USD/Kg) and Trend Forecast (2018-2025)
Table Global Anticoagulant Drugs Sales Volume (MT) Forecast by Regions (2018-2025)
Figure Global Anticoagulant Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Anticoagulant Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Anticoagulant Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Anticoagulant Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Anticoagulant Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Europe Anticoagulant Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure China Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Japan Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Anticoagulant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure India Anticoagulant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Anticoagulant Drugs Sales (MT) Forecast by Type (2018-2025)
Figure Global Anticoagulant Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Anticoagulant Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anticoagulant Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Anticoagulant Drugs Price (USD/Kg) Forecast by Type (2018-2025)
Table Global Anticoagulant Drugs Sales (MT) Forecast by Application (2018-2025)
Figure Global Anticoagulant Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

抗凝固薬、未分画ヘパリン、ワルファリン、低分子量ヘパリン、 第Xa因子インヒビター、直接阻害インヒビター、病院、研究所

★調査レポート[抗凝固薬の世界市場:販売動向2018] (コード:QYR80700901)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗凝固薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆